NCT03913468View on ClinicalTrials.gov

Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.

CompletedOBSERVATIONAL

Enrollment

206

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions

Septic ShockAscorbic Acid Deficiency

Interventions

DRUG

Intravenous Ascorbic Acid

1.5 grams IV ascorbic acid q6h, 50 mg IV hydrocortisone q 6 hours, and 200mg IV thiamine BID administered (as documented in medical record)

Trial Locations (1)

53705

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors

lead

University of Wisconsin, Madison

OTHER

NCT03913468 - Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine. | Biotech Hunter | Biotech Hunter